Pharma's 2 Biggest Setbacks in 2018

Pharma's 2 Biggest Setbacks in 2018

Source: 
Motley Fool
snippet: 

AbbVie and Celgene are pharma's two biggest losers in terms of clinical development this year. But that doesn't mean investors should shy away from these two names.